A
What happened
For the first time, Japan has approved the over-the-counter sale of the emergency contraceptive pill, Norlevo, enabling women to obtain it without a prescription. ASKA Pharmaceutical announced this significant development, emphasizing that it will empower women regarding their reproductive health. The pill will be labeled as 'medicine requiring guidance,' meaning it must be taken in the presence of a pharmacist. Previously, access was limited to clinics or pharmacies with a doctor's prescription. The approval follows a public consultation in 2017 that showed strong support for easier access, although officials had previously hesitated due to concerns about potential misuse. The pill is effective within 72 hours after unprotected sex and has an efficacy rate of 80%. This change is seen as a crucial step in addressing the conservative views on women's reproductive rights in Japan.
★
Key insights
-
1
Empowerment for Women
The approval enhances women's autonomy over reproductive health.
-
2
Historical Shift
This marks a significant change in Japan's contraceptive policies.
-
3
Public Support
Strong public backing was evident during consultations for this change.
Takeaways
The approval of the over-the-counter morning-after pill in Japan represents a pivotal moment in women's reproductive rights, reflecting changing attitudes and increasing support for accessible healthcare.